New Slow-Release drug for muscle weakness tested in healthy volunteers
NCT ID NCT07154095
First seen Nov 01, 2025 · Last updated Jun 02, 2026 · Updated 28 times
Summary
This study tested a new slow-release form of pyridostigmine, a drug used for myasthenia gravis (a muscle weakness disease), against the regular tablet. Forty healthy adults took both versions to see how the drug is absorbed and if it's safe. The goal was to gather information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West China Second University Hospital
Chengdu, China
Conditions
Explore the condition pages connected to this study.